rs11558748

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000267996.11(TPM1):​c.*31G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0026 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00083 ( 1 hom. )

Consequence

TPM1
ENST00000267996.11 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0320

Publications

13 publications found
Variant links:
Genes affected
TPM1 (HGNC:12010): (tropomyosin 1) This gene is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The encoded protein is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy and dilated cardiomyopathy 1Y. [provided by RefSeq, Jun 2022]
TPM1 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
  • dilated cardiomyopathy 1Y
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • left ventricular noncompaction
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 15-63071203-G-A is Benign according to our data. Variant chr15-63071203-G-A is described in ClinVar as Benign. ClinVar VariationId is 257060.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0854 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TPM1NR_176337.1 linkn.1045G>A non_coding_transcript_exon_variant Exon 10 of 10
TPM1NR_176338.1 linkn.2265G>A non_coding_transcript_exon_variant Exon 10 of 10
TPM1NR_176340.1 linkn.1064G>A non_coding_transcript_exon_variant Exon 10 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TPM1ENST00000267996.11 linkc.*31G>A 3_prime_UTR_variant Exon 9 of 9 1 ENSP00000267996.7
TPM1ENST00000358278.7 linkc.*31G>A 3_prime_UTR_variant Exon 9 of 9 1 ENSP00000351022.3
TPM1ENST00000404484.9 linkc.*31G>A 3_prime_UTR_variant Exon 8 of 8 1 ENSP00000384315.4

Frequencies

GnomAD3 genomes
AF:
0.00252
AC:
22
AN:
8726
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00200
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00407
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.250
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00259
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00657
AC:
69
AN:
10502
AF XY:
0.00501
show subpopulations
Gnomad AFR exome
AF:
0.00671
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00309
Gnomad EAS exome
AF:
0.150
Gnomad FIN exome
AF:
0.00478
Gnomad NFE exome
AF:
0.00547
Gnomad OTH exome
AF:
0.00741
GnomAD4 exome
AF:
0.000827
AC:
188
AN:
227210
Hom.:
1
Cov.:
0
AF XY:
0.000782
AC XY:
91
AN XY:
116424
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00161
AC:
10
AN:
6210
American (AMR)
AF:
0.00
AC:
0
AN:
6522
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4952
East Asian (EAS)
AF:
0.00319
AC:
8
AN:
2510
South Asian (SAS)
AF:
0.00129
AC:
24
AN:
18638
European-Finnish (FIN)
AF:
0.000437
AC:
5
AN:
11446
Middle Eastern (MID)
AF:
0.00304
AC:
3
AN:
988
European-Non Finnish (NFE)
AF:
0.000764
AC:
127
AN:
166324
Other (OTH)
AF:
0.00114
AC:
11
AN:
9620
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.395
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00263
AC:
23
AN:
8736
Hom.:
0
Cov.:
0
AF XY:
0.00264
AC XY:
11
AN XY:
4168
show subpopulations
African (AFR)
AF:
0.00225
AC:
9
AN:
4006
American (AMR)
AF:
0.00407
AC:
2
AN:
492
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
218
East Asian (EAS)
AF:
0.250
AC:
4
AN:
16
South Asian (SAS)
AF:
0.00
AC:
0
AN:
92
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
634
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
26
European-Non Finnish (NFE)
AF:
0.00259
AC:
8
AN:
3092
Other (OTH)
AF:
0.00
AC:
0
AN:
120
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00758
Hom.:
7

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.7
DANN
Benign
0.58
PhyloP100
0.032
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11558748; hg19: chr15-63363402; COSMIC: COSV51260760; COSMIC: COSV51260760; API